
Antiviral restriction factors are host cellular proteins that constitute a first line of defense blocking viral replication and propagation. In addition to interfering at critical steps of the viral replication cycle, some restriction factors also act as innate sensors triggering innate responses against infections. Accumulating evidence suggests an additional role for restriction factors in promoting antiviral cellular immunity to combat viruses. Here, we review the recent progress in our understanding on how restriction factors, particularly APOBEC3G, SAMHD1, Tetherin, and TRIM5α have the cell-autonomous potential to induce cellular resistance against HIV-1 while promoting antiviral innate and adaptive immune responses. Also, we provide an overview of how these restriction factors may connect with protein degradation pathways to modulate anti-HIV-1 cellular immune responses, and we summarize the potential of restriction factors-based therapeutics. This review brings a global perspective on the influence of restrictions factors in intrinsic, innate, and also adaptive antiviral immunity opening up novel research avenues for therapeutic strategies in the fields of drug discovery, gene therapy, and vaccines to control viral infections.
CD4-Positive T-Lymphocytes, Ubiquitin-Protein Ligases, Adaptive immunity, Immunology, HIV Infections, virus, APOBEC-3G Deaminase, Adaptive Immunity, GPI-Linked Proteins, Virus Replication, Antiviral Restriction Factors, SAM Domain and HD Domain-Containing Protein 1, Tripartite Motif Proteins, Antigens, CD, Humans, [SDV.IMM.II] Life Sciences [q-bio]/Immunology/Innate immunity, Degradation pathways, innate immunity, Innate immunity, degradation pathways, Immunity, Cellular, Virion, adaptive immunity, RC581-607, immunotherapies, restriction factors, Immunity, Innate, Virus, [SDV.IMM.IA] Life Sciences [q-bio]/Immunology/Adaptive immunology, Host-Pathogen Interactions, Proteolysis, HIV-1, RNA, Viral, Restriction factors, Immunologic diseases. Allergy, Immunotherapies, Carrier Proteins
CD4-Positive T-Lymphocytes, Ubiquitin-Protein Ligases, Adaptive immunity, Immunology, HIV Infections, virus, APOBEC-3G Deaminase, Adaptive Immunity, GPI-Linked Proteins, Virus Replication, Antiviral Restriction Factors, SAM Domain and HD Domain-Containing Protein 1, Tripartite Motif Proteins, Antigens, CD, Humans, [SDV.IMM.II] Life Sciences [q-bio]/Immunology/Innate immunity, Degradation pathways, innate immunity, Innate immunity, degradation pathways, Immunity, Cellular, Virion, adaptive immunity, RC581-607, immunotherapies, restriction factors, Immunity, Innate, Virus, [SDV.IMM.IA] Life Sciences [q-bio]/Immunology/Adaptive immunology, Host-Pathogen Interactions, Proteolysis, HIV-1, RNA, Viral, Restriction factors, Immunologic diseases. Allergy, Immunotherapies, Carrier Proteins
| citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 136 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 1% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 1% |
